16.01.2014 • Topics
Helsinn Reaps Benefits of Cytotoxic Molecule Demand
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
Company
Helsinn Chemicals SAVia Industria 24
6710 Biasca
Switzerland
most read
Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0
ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.
US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.
Q1 2025 Chemical Industry: Diverging Trends
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.
Lead or Lag: Europe’s AI Materials Race
How AI and Robotics are reshaping the race for materials discovery.